LONDON/NEW YORK (Reuters) – Sanofi SA is looking to sell a portfolio of older drugs that could fetch $7-8 billion, according to people familiar with the matter, yet another example of drugmakers trying to shed non-core assets and focus on high-growth areas.
The French pharmaceutical…
Exclusive: Sanofi explores $7 billion-plus sale of drug portfolio
No comments:
Post a Comment